相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Next generation topoisomerase I inhibitors: Rationale and biomarker strategies
Beverly A. Teicher
BIOCHEMICAL PHARMACOLOGY (2008)
Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission
Olivier Sordet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts
Thomas S. Dexheimer et al.
NUCLEIC ACIDS RESEARCH (2008)
Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants
Supaart Sirikantaramas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topolsomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death
Agneyo Ganguly et al.
CANCER RESEARCH (2007)
Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters
Kazutaka Takagi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topolsomerase I cleavage complexes and overcome multidrug resistance
Smitha Antony et al.
CANCER RESEARCH (2007)
Nitrated indenoisoquinolines as topoisomerase I inhibitors: A systematic study and optimization
Andrew Morrell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase i inhibition and cytotoxicity in human cancer cell cultures
Andrew Morrell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex
N. Sen et al.
CELL DEATH AND DIFFERENTIATION (2007)
Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled manner
A. Rockstroh et al.
ONCOGENE (2007)
A systematic study of nitrated indenoisoquinolines reveals a potent topoisomerase I inhibitor
Andrew Morrell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes
Olivier Sordet et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity
Smitha Antony et al.
MOLECULAR PHARMACOLOGY (2006)
Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay
Andrew Morrell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs
AK McClendon et al.
BIOCHEMISTRY (2006)
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
C Marchand et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Esters and amides of 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine-12-carboxylic acid:: Potent cytotoxic and topoisomerase I-targeting agents
SJ Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis
A Ioanoviciu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex
BL Staker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB
DA Koster et al.
NATURE (2005)
Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1
SF El-Khamisy et al.
NATURE (2005)
Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison
S Antony et al.
MOLECULAR PHARMACOLOGY (2005)
Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases
HL Zhang et al.
NUCLEIC ACIDS RESEARCH (2004)
The human topoisomerase I damage response plays a role in apoptosis
K Soe et al.
DNA REPAIR (2004)
Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis
O Sordet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gimatecan, a novel camptothecin with a promising preclinical profile
G Pratesi et al.
ANTI-CANCER DRUGS (2004)
Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals
O Sordet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures
S Antony et al.
NUCLEIC ACIDS RESEARCH (2004)
Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N-2-ethyl-2 '-deoxyguanosine
S Antony et al.
NUCLEIC ACIDS RESEARCH (2004)
Analysis of human topoisomerase I inhibition and interaction with the cleavage site+1 deoxyguanosine, via in vitro experiments and molecular modeling studies
GS Laco et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin
P Hautefaye et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Structural impact of the leukemia drug 1-β-D-arabinofuranosyleytosine (Ara-C) on the covalent human topoisomerase I-DNA complex
JE Chreneik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs
C Bailly
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
The mechanism of topoisomerase I poisoning by a camptothecin analog
BL Staker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
8-oxoguanine rearranges the active site of human topoisomerase I
DTT Lesher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Different effects on human topoisomerase I by minor groove and intercalated deoxyguanosine adducts derived from two polycyclic aromatic hydrocarbon diol epoxides at or near a normal cleavage site
Y Pommier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Human mitochondrial topoisomerase I
HL Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]pyrene diol epoxide adducts at the 6-amino group of adenine
Y Pommier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Essential functions of DNA topoisomerase I in Drosophila melanogaster
CX Zhang et al.
DEVELOPMENTAL BIOLOGY (2000)
Conversion of topoisomerase 1 cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff
D Strumberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages
Y Pommier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Topoisomerase I poisons and suppressors as anticancer drugs
C Bailly
CURRENT MEDICINAL CHEMISTRY (2000)
分享论文
